Characterizing adolescent vaccination in publicly funded national immunization programs in Latin America and the Caribbean: A review of the literature
- PMID: 40643044
- PMCID: PMC12258168
- DOI: 10.1080/21645515.2025.2528403
Characterizing adolescent vaccination in publicly funded national immunization programs in Latin America and the Caribbean: A review of the literature
Abstract
This review aimed to characterize adolescent vaccination schedules in publicly funded national immunization programs in Latin America and the Caribbean. The initial review identified vaccine type, target age and gender, dose schedule, and vaccination coverage rate (VCR) across 50 countries/territories in the region. A systematic review from January 2010-October 2023 was then conducted to identify primary data collection studies reporting VCRs. Overall, 42 webpages and 23 primary studies were identified. Among 47 countries/territories with ≥1 vaccine for adolescent immunization, human papillomavirus (HPV) vaccine was included in 45, tetanus component vaccines in 43, and meningococcal vaccines in 10. Catch-up vaccination for hepatitis B in 17, and yellow fever in all 13 endemic countries/territories. VCRs were primarily available for HPV. The findings of this review underscore the need to prioritize adolescent vaccination, improve accessibility, and strengthen tracking infrastructure to ensure comprehensive protection of this age group across the region.
Keywords: Adolescent; Latin America and Caribbean; immunization; vaccination coverage; vaccine uptake; vaccines.
Conflict of interest statement
Monica Rojas is an employee of MSD Colombia, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA, who may own stock and/or hold stock options in Merck & Co., Inc., Rahway, NJ, USA; Maria Florencia Lución and Ivan Felipe Gutierrez Tobar have declared no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper; Ricardo Becker Feijó has received honoraria for lectures, presentations, educational events and support for attending meetings and/or travel from Pfizer, MSD, GSK and Sanofi; Antonio Luevanos has received honoraria for lectures, presentations, educational events and support for attending meetings and/or travel from MSD; Dora Estripeaut has received honoraria for lectures, presentations, educational events and/or support for attending meetings and/or travel from Pfizer, Sanofi and MSD; Andrea Schilling has received honoraria for lectures, presentations, educational events, and support for attending meetings and/or travel from Pfizer and MSD; Jessica Webster participated in a paid internship of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA; Maria Eugenia Perez is an employee of MSD Argentina, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA, who may own stock and/or hold stock options in Merck & Co., Inc., Rahway, NJ, USA; Juan Carlos Orengo is an employee of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA, who may own stock and/or hold stock options in Merck & Co., Inc., Rahway, NJ, USA; Cintia Irene Parellada and Luciana Hirata are employees of MSD Brazil, a subsidiary of Merck & Co., Inc., Rahway, NJ, USA, who may own stock and/or hold stock options in Merck & Co., Inc., Rahway, NJ, USA.
Figures


Similar articles
-
Overcoming challenges and achieving high HPV vaccination uptake in Cameroon: lessons learned from a gender-neutral and single-dose program and community engagement.BMC Public Health. 2025 May 8;25(1):1696. doi: 10.1186/s12889-025-22776-3. BMC Public Health. 2025. PMID: 40340822 Free PMC article.
-
Sixteen Years of HPV Vaccination in Mexico: Report of the Coverage, Procurement, and Program Performance (2008-2023).Int J Environ Res Public Health. 2025 Jun 27;22(7):1028. doi: 10.3390/ijerph22071028. Int J Environ Res Public Health. 2025. PMID: 40724094 Free PMC article.
-
Strategies to increase immunization coverage of tetanus vaccine among women in Sub Saharan Africa: a systematic review.Pan Afr Med J. 2017 Jun 22;27(Suppl 3):25. doi: 10.11604/pamj.supp.2017.27.3.11535. eCollection 2017. Pan Afr Med J. 2017. PMID: 29296160 Free PMC article.
-
Inconclusive evidence for non-inferior immunogenicity of two- compared with three-dose HPV immunization schedules in preadolescent girls: A systematic review and meta-analysis.J Infect. 2015 Jul;71(1):61-73. doi: 10.1016/j.jinf.2015.02.005. Epub 2015 Feb 21. J Infect. 2015. PMID: 25709084
-
Estimating the health effects of COVID-19-related immunisation disruptions in 112 countries during 2020-30: a modelling study.Lancet Glob Health. 2024 Apr;12(4):e563-e571. doi: 10.1016/S2214-109X(23)00603-4. Lancet Glob Health. 2024. PMID: 38485425 Free PMC article.
References
-
- World Health Organization . Working for a brighter, healthier future: how WHO improves health and promotes well-being for the world’s adolescents. 2021. [accessed 2023 Jan 10]. https://reliefweb.int/report/world/working-brighter-healthier-future-how....
-
- United Nations (UN) . Transforming our world: the 2030 agenda for sustainable development. United Nations; 2015. [accessed 2024 Apr 20]. https://sdgs.un.org/2030agenda.
-
- Pan American Health Organization . No time to lose: health challenges for adolescents in Latin America and the Caribbean. Washington, DC: PAHO; 2022. [accessed 2025 May 18]. https://www.paho.org/en/documents/reportno-time-lose-health-challenges-a....
-
- World Health Organization . Global accelerated action for the health of adolescents (AA-HA!): guidance to support country implementation. Geneva: WHO; 2017. [accessed 2025 May 18]. https://www.who.int/publications/i/item/9789241512343.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical